Soleus Capital Management as of June 30, 2021
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 65 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bioatla (BCAB) | 18.2 | $118M | 2.8M | 42.38 | |
Essa Pharma Com New (EPIX) | 9.8 | $64M | 2.2M | 28.57 | |
C4 Therapeutics Com Stk (CCCC) | 5.1 | $33M | 871k | 37.84 | |
Neuropace (NPCE) | 5.1 | $33M | 1.4M | 23.79 | |
Theratechnologies | 4.2 | $27M | 7.0M | 3.88 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 3.9 | $25M | 914k | 27.64 | |
Novocure Ord Shs (NVCR) | 3.4 | $22M | 99k | 221.82 | |
Edap Tms S A Sponsored Adr (EDAP) | 2.8 | $18M | 2.6M | 7.09 | |
Iveric Bio | 2.7 | $18M | 2.8M | 6.31 | |
Crispr Therapeutics Namen Akt (CRSP) | 2.6 | $17M | 103k | 161.89 | |
Neogenomics Com New (NEO) | 2.4 | $16M | 352k | 45.17 | |
The Beauty Health Company Com Cl A (SKIN) | 2.4 | $16M | 934k | 16.80 | |
SurModics (SRDX) | 2.3 | $15M | 278k | 54.25 | |
Astrazeneca Sponsored Adr (AZN) | 2.3 | $15M | 250k | 59.90 | |
Iradimed (IRMD) | 2.2 | $15M | 497k | 29.41 | |
Itamar Med Sponsored Ads | 1.9 | $13M | 531k | 23.55 | |
CVRX (CVRX) | 1.8 | $12M | 426k | 28.00 | |
Sientra | 1.8 | $12M | 1.5M | 7.96 | |
Natera (NTRA) | 1.8 | $12M | 102k | 113.53 | |
Werewolf Therapeutics (HOWL) | 1.5 | $9.8M | 563k | 17.44 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 1.3 | $8.6M | 11M | 0.80 | |
Vaxcyte (PCVX) | 1.3 | $8.5M | 376k | 22.51 | |
Evolus (EOLS) | 1.1 | $7.3M | 580k | 12.65 | |
Inhibrx | 1.0 | $6.7M | 243k | 27.52 | |
Editas Medicine (EDIT) | 0.8 | $5.4M | 96k | 56.64 | |
Cutera (CUTR) | 0.8 | $5.0M | 103k | 49.03 | |
Y Mabs Therapeutics (YMAB) | 0.7 | $4.9M | 144k | 33.80 | |
Compass Pathways Sponsored Ads (CMPS) | 0.7 | $4.9M | 128k | 38.15 | |
Krystal Biotech (KRYS) | 0.7 | $4.6M | 68k | 68.00 | |
Assembly Biosciences | 0.7 | $4.4M | 1.1M | 3.88 | |
Xenon Pharmaceuticals (XENE) | 0.7 | $4.4M | 234k | 18.62 | |
Inspire Med Sys (INSP) | 0.6 | $4.2M | 22k | 193.27 | |
MiMedx (MDXG) | 0.6 | $4.0M | 322k | 12.51 | |
Revolution Medicines (RVMD) | 0.6 | $4.0M | 126k | 31.74 | |
Celcuity (CELC) | 0.6 | $4.0M | 165k | 24.00 | |
Pulmonx Corp (LUNG) | 0.6 | $3.8M | 85k | 44.12 | |
Dyne Therapeutics (DYN) | 0.6 | $3.8M | 178k | 21.04 | |
Axogen (AXGN) | 0.5 | $3.4M | 158k | 21.61 | |
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.5 | $3.2M | 300k | 10.72 | |
Bridgebio Pharma Note 2.500% 3/1 (Principal) | 0.5 | $3.2M | 2.0M | 1.64 | |
Beam Therapeutics (BEAM) | 0.4 | $2.8M | 22k | 128.69 | |
Galecto | 0.4 | $2.7M | 538k | 5.06 | |
Alpha Teknova (TKNO) | 0.4 | $2.7M | 115k | 23.73 | |
Caredx (CDNA) | 0.4 | $2.7M | 29k | 91.54 | |
Dex (DXCM) | 0.4 | $2.5M | 5.9k | 426.92 | |
Insulet Corporation (PODD) | 0.4 | $2.5M | 9.0k | 274.50 | |
4d Molecular Therapeutics In (FDMT) | 0.4 | $2.4M | 101k | 24.08 | |
Establishment Labs Holdings Ord (ESTA) | 0.4 | $2.3M | 27k | 87.32 | |
Misonix | 0.3 | $2.2M | 101k | 22.18 | |
Guardant Health (GH) | 0.3 | $2.2M | 18k | 124.17 | |
Halozyme Therapeutics (HALO) | 0.3 | $2.0M | 44k | 45.42 | |
Rafael Hldgs Com Cl B (RFL) | 0.3 | $1.9M | 37k | 51.06 | |
Eiger Biopharmaceuticals | 0.3 | $1.8M | 214k | 8.52 | |
Monte Rosa Therapeutics (GLUE) | 0.3 | $1.7M | 75k | 22.71 | |
Catabasis Pharmaceuticals In Com New | 0.3 | $1.6M | 775k | 2.11 | |
Caremax Com Cl A | 0.2 | $1.5M | 119k | 12.90 | |
Lyra Therapeutics (LYRA) | 0.2 | $1.5M | 183k | 8.03 | |
Renalytix Ads (RNLXY) | 0.2 | $1.5M | 47k | 30.87 | |
Silverback Therapeutics (SPRY) | 0.1 | $967k | 31k | 30.89 | |
Magenta Therapeutics | 0.1 | $880k | 90k | 9.78 | |
Tcr2 Therapeutics Inc cs | 0.1 | $780k | 48k | 16.41 | |
Edgewise Therapeutics (EWTX) | 0.1 | $668k | 31k | 21.34 | |
Inari Medical Ord (NARI) | 0.1 | $574k | 6.2k | 93.33 | |
Kadmon Hldgs | 0.1 | $335k | 86k | 3.88 | |
Repare Therapeutics Ord (RPTX) | 0.0 | $228k | 7.3k | 31.23 |